Navigation On Topic Complete Directory About Us Add-site Link to Us

220 Health - AIDS Resources $50 billion needed for global AIDS control As Congress considers the renewal of PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program, over the coming weeks, AIDS Healthcare Foundation (AHF) President Michael Weinstein offers the following commentary regarding what is needed in the global fight against HIV/AIDS: Open Open Tab May 25, 2008 Provides Information 70s TV Star Passed AIDS Immunity Gene To His Son Jake Glaser's mother and young sister died of AIDS-related complications, and he's HIV-positive, but lives symptom-free, and doesn't even take medicine to keep the virus at bay anymore. Open Open Tab June 12, 2008 Provides Information A A Protein's Role In Enabling AIDS Virus To Reproduce Detailed The findings are significant because they suggest new strategies to prevent replication, and because they are applicable to human strains of the virus, which, despite the persistent efforts of scientists over two decades, can only be slowed by drug treatments but neither cured nor prevented. Open Open Tab May 27, 2008 Provides Information About One-quarter Of Women With HIV Want To Become Pregnant About one in four women who have tested positive for the human immunodeficiency virus (HIV) expect pregnancy and motherhood to be a part of their future, recent research suggests. Open Open Tab February 27, 2008 Provides Information ACLU: Peace Corps Fired Volunteer for Having HIV Jeremiah S. Johnson was enjoying his work with the Peace Corps. He had taught English to teenagers in Rozdilna, Ukraine and was even thinking of trying to open an English resource center there. Open Open Tab April 28, 2008 Provides Information AIDS Healthcare Foundation names new chief of medicine: Homayoon Khanlou, M.D. In addition to his extensive experience as a practicing HIV/AIDS physician, Dr. Khanlou is also a leading clinical researcher whose research has been published in such prestigious periodicals as the New England Journal of Medicine and the Archives of Internal Medicine. Open Open Tab August 28, 2007 Provides Information AIDS Healthcare Foundation's innovative "Stay Negative" campaign successfully breaks through to target audience A post-campaign survey of AIDS Healthcare Foundation's (AHF) innovative "Stay Negative" social marketing campaign recently revealed the initiative's success at breaking through to its target audience and reaching its objective to create an effective health education and risk reduction campaign to raise awareness among gay males in Los Angeles County that HIV infection is still a serious threat. Open Open Tab October 7, 2007 Provides Information AIDS May be Cured by Nanotechnology With Nanoemulsion Nasal Vaccine Producing Immunity to HIV, Smallpox and Other Infectious Diseases A novel technique for vaccinating against a variety of infectious diseases – using an oil-based emulsion placed in the nose, rather than needles – has proved able to produce a strong immune response against smallpox and HIV in two new studies. Open Open Tab February 27, 2008 Provides Information AIDS May Partly Be The Consequence Of An Evolutionary Accident AIDS, a fatal disease in humans, may partly be the consequence of an evolutionary accident, scientists explained April 1, 2008 at the Society for General Microbiology's 162nd meeting being held at the Edinburgh International Conference Centre. Open Open Tab April 3, 2008 Provides Information AIDS Not The Downfall Of African Families Her study shows that AIDS compounds the issue of poverty in households where poverty is already a prevailing issue, especially when a household loses its primary income earner to AIDS. Open Open Tab August 23, 2007 Provides Information AIDS Vaccine Advocacy Coalition receives $14 million from Gates Foundation The AIDS Vaccine Advocacy Coalition (AVAC) announced today at the AIDS Vaccine 2007 Conference that it has received a five-year, $14 million grant from the Bill & Melinda Gates Foundation to create a new international HIV Prevention Research Advocacy Network. Open Open Tab August 21, 2007 Provides Information Alcohol Consumption Linked To HIV Disease Progression Researchers from Boston University School of Medicine (BUSM) have found a link between alcohol consumption and HIV disease progression in HIV-infected persons. Open Open Tab August 22, 2007 Provides Information An AIDS-related Virus Reveals More Ways To Cause Cancer Researchers at the University of Pennsylvania School of Medicine have shed new light on how Kaposi's Sarcoma-associated Herpes Virus (KSHV) subverts normal cell machinery to cause cancer. Open Open Tab October 10, 2007 Provides Information Anti-retrovirals given daily before and after exposure to HIV prevent vaginal transmission AIDS virus Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found. Open Open Tab January 15, 2008 Provides Information Apotex receives final tender approval from Rwanda for vital AIDS drug Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR). Open Open Tab May 7, 2008 Provides Information Approval for once-a-day HIV pill The first HIV medication which involves taking just one pill a day has been approved by the European authorities. Open Open Tab December 17, 2007 Provides Information Are HIV Prevention Gels Safe For Pregnant Women, Their Babies? Clinical trials hoping to identify a vaginal microbicide that is both safe and effective against HIV have all but skirted questions befitting the evaluation of an approach intended primarily for sexually active women of childbearing age: What if a woman becomes pregnant while using a product? Can exposure to a product, especially early in pregnancy, pose a risk to the developing fetus? Does pregnancy affect how a particular microbicide is supposed to work? Open Open Tab June 17, 2008 Provides Information Asthma risk increases in children treated for HIV Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, said a federally funded consortium of researchers led by those from Baylor College of Medicine in a report that appears online in the Journal of Allergy and Clinical Immunology. Open Open Tab July 1, 2008 Provides Information B Barack Obama pledges to increase spending on global HIV/AIDS to $50 billion Barack Obama has stepped ahead of all other candidates for President in one of the most critical areas of foreign policy, the effort to eradicate extreme poverty. Open Open Tab November 1, 2007 Provides Information Battle Looms Over Bush's Global AIDS Spending A five-year, $15 billion effort to combat AIDS in Africa and other areas — arguably the most important and popular international program of the Bush presidency — may become a political battleground as it comes up for renewal. Open Open Tab February 2, 2008 Provides Information Bill Gates digs deep in his pocket for AIDS The University of Maryland has been awarded a grant worth $15 Million by the Bill & Melinda Gates Foundation to develop an HIV/AIDS vaccine. Open Open Tab August 1, 2007 Provides Information Blood-free monitoring as good as blood tests in predicting the course of AIDS Researchers at the University of Pennsylvania School of Medicine have shown that monitoring treatment adherence to AIDS therapy is a simple blood-free way to monitor risk of disease progression. Open Open Tab May 20, 2008 Provides Information Bronx wants HIV tests for all adults in borough Officials aim to test quarter million in borough that's been hit hard by AIDS Open Open Tab June 26, 2008 Provides Information Boston Trial to Test New HIV/AIDS Vaccine A new HIV/AIDS vaccine designed to overcome the problem of preexisting immunity to common vaccine vectors is being tested in an early clinical trial at Brigham and Women's Hospital in Boston. Open Open Tab April 11, 2008 Provides Information Botswana pilots anger at HIV move Pilots in Botswana have reacted angrily to new regulations that mean they could face the sack if they have HIV. Open Open Tab August 16, 2007 Provides Information Botswana President says AIDS-related deaths decreasing According to UNAIDS, about 270,000 people are living with HIV/AIDS in Botswana, and 85% of people in need of treatment receive drugs at no cost from the government. The country hopes to halt all new HIV cases by 2016. Open Open Tab November 6, 2007 Provides Information C California passes historic HIV testing bill The bill removes a major barrier to HIV testing by requiring a patient to give simple consent, rather than informed consent, before an HIV test can be administered. Open Open Tab September 11, 2007 Provides Information CDC Director Gerberding calls for increase in HIV prevention efforts for black community CDC Director Julie Gerberding on Friday at a forum in Oakland, Calif., said that more money is needed to fight HIV/AIDS in the black community, particularly among black men who have sex with men. Open Open Tab May 13, 2008 Provides Information CDC report on new HIV cases among MSM shows need to continue prevention, treatment efforts CDC's recently released HIV/AIDS data, which show an overall increase in new HIV diagnoses among men who have sex with men, is a "reminder that the work of keeping people HIV-negative and getting those who are HIV-positive into treatment is never done". Open Open Tab July 2, 2008 Provides Information Circumcision Safe In Both HIV-infected And HIV-uninfected Men, Study Finds Adult circumcision is safe in HIV-infected men without advanced HIV disease, according to research published in PLoS Medicine. Open Open Tab June 4, 2008 Provides Information Climate change could increase HIV infection rates world-wide Social factors, including economic pressures caused by climate change, could lead to an increase in HIV infection rates world-wide, warns a leading researcher from the University of New South Wales (UNSW). Open Open Tab April 30, 2008 Provides Information Clinic That May Have Infected 40,000 With HIV, Hepatitis Closed The city of Las Vegas has shut down a clinic where up to 40,000 people may have been exposed to hepatitis C and the HIV virus through the reuse of syringes and vials. Open Open Tab March 3, 2008 Provides Information Clinton signs pledge to commit to fight against HIV/AIDS The Global AIDS Alliance Fund and other groups have called on U.S. presidential candidates to sign the pledge, which asks candidates to commit $50 billion to HIV/AIDS efforts. Open Open Tab October 30, 2007 Provides Information CNN Heroes: Giving hope to orphans of AIDS Born and bred in Malawi, in southern Africa, Da Silva lost 14 family members, including her father and 2 brothers, to the disease. Open Open Tab March 23, 2008 Provides Information Compound Has Potential For New Class Of AIDS Drugs Researchers have developed what they believe is the first new mechanism in nearly 20 years for inhibiting a common target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs. Open Open Tab May 19, 2008 Provides Information Counseling heterosexual couples about HIV in Zambia, Rwanda could prevent 60% of HIV cases Of the new HIV cases examined in the study, between 55.1% and 92.7% occurred among "serodiscordant" couples -- in which one partner is HIV-positive and the other is not. Open Open Tab July 2, 2008 Provides Information Corporate world is helping employees deal with the global HIV/AIDS epidemic Major companies are creating a wide variety of programs to help employees deal with the global HIV/AIDS epidemic, according to a report released by The Conference Board, the global business research and membership organization. Open Open Tab April 13, 2008 Provides Information Court puts on hold HIV decision A court in India's Rajasthan state has put on hold a controversial decision by a lower court denying an HIV-positive woman the custody of her daughter. Open Open Tab September 28, 2007 Provides Information D Decline In Blood Platelet Count Associated With Increased Risk Of HIV-related Dementia Therapies leading to longer life for HIV patients have paradoxically increased the prevalence of this condition. Open Open Tab September 16, 2007 Provides Information Delegates agree to focus on HIV/AIDS, other issues hindering African development at close of Tokyo conference The delegates also reaffirmed commitments to increase efforts to fight HIV/AIDS, malnutrition, and infant and maternal mortality on the continent. In addition, the delegates called on the Group of Eight industrialized nations to honor their commitments to provide development aid to Africa. Open Open Tab June 2, 2008 Provides Information Denial of care for HIV+ detainees 'unacceptable,' says AHF On the heels of the Human Rights Watch report descrying the treatment of HIV-positive immigrant detainees, AIDS Healthcare Foundation (AHF) has criticized the U.S. Department of Homeland Security (DHS) for its callous disregard for the health and well-being of people living with HIV/AIDS in its care. Open Open Tab December 10, 2007 Provides Information Did HIV Arrive Earlier Than Thought? HIV, the Virus That Causes AIDS, May Have Reached the U.S. 12 Years Before AIDS Recognition. Open Open Tab October 29, 2007 Provides Information Do Antidepressants Enhance Immune Function? Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. Open Open Tab May 9, 2008 Provides Information Doctors failing to diagnose HIV early in UK Africans Doctors are missing valuable opportunities to diagnose HIV in Africans living in the UK, with serious consequences for their long term health. Open Open Tab December 10, 2007 Provides Information Doctors See Return of Kaposi's Sarcoma in Handful of AIDS Patients San Francisco doctors say they've seen a small number of longtime HIV patients with mild cases of Kaposi's sarcoma, a potentially dangerous condition that once plagued people with AIDS. Open Open Tab September 26, 2007 Provides Information Does Treating Worms In People With HIV Slow Progression To AIDS? Of the 25 million people infected with HIV-1 in Africa, as many as half are thought to be co-infected with worms (helminths), and there is evidence that these worms may result in a more rapid progression of HIV infection to AIDS. Does treating these worms ("de-worming") slow down this progression? Open Open Tab December 19, 2007 Provides Information Draft G8 communique does not cite 2010 deadlines for development aid, universal access to HIV prevention, care A draft communique scheduled to be issued at the Group of Eight industrialized nations summit in July in Hokkaido, Japan, does not cite 2010 targets for universal access to HIV/AIDS prevention, care and treatment or for $25 billion in annual aid to Africa that were set at the 2005 G8 summit in Gleneagles, Scotland. Open Open Tab July 2, 2008 Provides Information Drug Cocktail Stops Brain Damage Caused By HIV The study involved 53 men and women with an average age of 38. The participants were given a combination of several antiretroviral drugs known as Highly Active Anti-Retroviral Therapy (HAART) for one year. Open Open Tab October 9, 2007 Provides Information Drug resistant staph deaths may surpass AIDS toll More than 90,000 Americans get potentially deadly infections each year from a drug-resistant staph "superbug," the government reported Tuesday in its first overall estimate of invasive disease caused by the germ. Open Open Tab October 16, 2007 Provides Information E Egypt police 'widen HIV arrests' Egyptian police have arrested four men suspected of being HIV positive, bringing the total detained in a recent crackdown to 12, rights groups say. Open Open Tab February 15, 2008 Provides Information Even Older Women At High Risk Have Little Interest In Being Tested For HIV Few older women were interested in being tested for the virus that causes AIDS despite having significant risk factors for lifetime exposure Open Open Tab August 10, 2007 Provides Information Exhaustion Of HIV-specific T Cells May Be Caused By Chronic Exposure To Virus The "exhaustion" of immune cells that target HIV appears to result from chronic exposure to the virus, specifically exposure to the particular protein segments targeted by the pathogen-killing HIV-specific CD8 T cells. Open Open Tab May 6, 2008 Provides Information F Failed HIV drug gets second chance with addition of gold nanoparticles Researchers at North Carolina State University have discovered that adding tiny bits of gold to a failed HIV drug rekindle the drug's ability to stop the virus from invading the body's immune system. Open Open Tab May 23, 2008 Provides Information Failed HIV Drug Gets Second Chance With Addition Of Gold Nanoparticles Researchers at North Carolina State University have discovered that adding tiny bits of gold to a failed HIV drug rekindle the drug's ability to stop the virus from invading the body's immune system. Open Open Tab May 27, 2008 Provides Information FDA approves maraviroc, an antiretroviral drug for use in adult HIV patients. The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA. Open Open Tab August 7, 2007 Provides Information FDA Probes Heart Risk From 2 HIV Drugs FDA Reviewing Heart Attack Data in HIV Patients Taking Ziagen and Videx. Open Open Tab March 31, 2008 Provides Information Feds Approve First New Class of HIV Meds Since 2003 The government approved a novel drug Monday to help patients with the AIDS virus who are running out of options, while acknowledging lingering questions about the pills' long-term effects. Open Open Tab August 7, 2007 Provides Information Fight Against HIV Needs Local Scientists Scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work. Open Open Tab October 29, 2007 Provides Information First medical textbook published that deals with management of HIV/AIDS globally The Academic Alliance Foundation announces the publishing of Global HIV/AIDS Medicine, the first medical textbook aimed at a comprehensive approach to the management of HIV/AIDS as a global problem. Open Open Tab January 9, 2008 Provides Information G Gene Mutations Tied To Immune Comeback During Therapy For HIV-1 A new study by U.S. scientists provides compelling evidence that two genes are linchpins in defining the course of immune restoration in HIV-positive individuals undergoing virus-suppressing therapy. Open Open Tab April 2, 2008 Provides Information Gene That Can Block The Spread Of HIV Discovered A team of researchers at the University of Alberta has discovered a gene that is able to block HIV, and in turn prevent the onset of AIDS. Open Open Tab February 29, 2008 Provides Information Genetic influence on HIV/AIDS progression Viral load - the amount of virus in the blood of an HIV-infected person - has long been viewed as the chief indicator of how quickly someone infected with HIV infection progresses to AIDS. Open Open Tab October 23, 2007 Provides Information Global AIDS rates up for drug users, gay men Report: Marginalized groups are refused care in some developing nations. Open Open Tab June 25, 2008 Provides Information Gold Nanoparticles Give Second Chance to Failed HIV Drug Researchers at North Carolina State University have discovered that adding tiny bits of gold to a failed HIV drug rekindle the drug's ability to stop the virus from invading the body's immune system. Open Open Tab May 26, 2008 Provides Information H Herpes Medication Does Not Reduce Risk Of HIV Infection In Individuals With HSV-2, Study Finds An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV. Researchers had hoped that acyclovir's ability to suppress the herpes virus, and its associated genital sores and breaks in the skin, could cut down on the likelihood of HIV being transmitted to a person with HSV-2 during sexual intercourse. Open Open Tab February 9, 2008 Provides Information HIV blocking gene found A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. Open Open Tab March 2, 2008 Provides Information HIV fears over Nepal sex workers Nearly 40% of Nepali women trafficked into India to work as sex workers there have been found to be HIV positive on their return home, a study has found. Open Open Tab August 1, 2007 Provides Information HIV funding priority shift call Funding for HIV prevention is being wasted on strategies which have little impact, say US researchers who call for a "dramatic shift" in priorities. Open Open Tab May 9, 2008 Provides Information HIV hides from drugs for years HIV can survive the apparently effective onslaught of antiviral drugs for years by hiding away in the body's cells, research shows. Open Open Tab March 11, 2008 Provides Information HIV Infection Stems From Few Viruses A new study reveals the genetic identity of human immunodeficiency virus (HIV), the version responsible for sexual transmission, in unprecedented detail. Open Open Tab May 19, 2008 Provides Information HIV is spread most by people with medium levels of HIV in blood People with medium levels of HIV in their blood are likely to contribute most to the spread of the virus. Open Open Tab October 23, 2007 Provides Information HIV patients living longer in developed nations Drug therapy reduces deaths of people infected through sex, study says. Open Open Tab July 1, 2008 Provides Information HIV patients suffer more from osteoporosis Following the introduction of HAART (Highly Active Antiretroviral Therapy), the survival and quality of life for people infected with the human immunodeficiency virus (HIV-1) have increased in the resource-rich countries. However, with this improved prognosis an increase in long term negative disorders has been observed, namely osteoporosis (the gradual loss of bone mass). Open Open Tab May 25, 2008 Provides Information HIV Persists In The Gut Despite Long-term HIV Therapy Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. One important reservoir is the gut, where HIV causes much of its damage due to the large number of HIV target cells that reside there. Open Open Tab February 14, 2008 Provides Information HIV rates among MSM vastly higher than general population in developing countries Responding to a new study demonstrating the severity of the HIV epidemic among men who have sex with men (MSM) in low- and middle-income countries, amfAR, the Foundation for AIDS Research, called on policymakers to put aside their prejudices and to provide the resources and the leadership that the epidemic demands. Open Open Tab December 3, 2007 Provides Information HIV test before Nigerian marriage Couples must first take an HIV test before they will be allowed to marry, the Anglican Church in Nigeria says. Open Open Tab August 17, 2007 Provides Information HIV Vaccine Not Effective, More Research Needed The new analyses revealed from the STEP HIV vaccine clinical trial are both disappointing and puzzling. Open Open Tab November 8, 2007 Provides Information HIV vaccine research hits impasse Scientists are no further forward in developing a vaccine against HIV after more than 20 years of research, a Nobel Prize-winning biologist has said. Open Open Tab February 15, 2008 Provides Information HIV vaccine trial volunteers asked to undergo testing to determine whether they are at increased risk of HIV Researchers have asked more than 3,000 people who participated in a trial of Merck's experimental HIV vaccine that was halted last month to undergo additional testing to determine if they are at an increased risk of HIV. Open Open Tab October 29, 2007 Provides Information HIV Vaccine Trials Begin Leading to Strong Hopes for AIDS Cure NanoViricides announced that preliminary animal trials of HivCide-I™, the Company's proposed HIV therapeutic, will begin soon at a BSL-3 facility in Boston, MA. The initial results are expected by the second week of May. Open Open Tab March 31, 2008 Provides Information HIV-1 vaccines may not be as reliable against superinfection as once thought Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens. Open Open Tab November 19, 2007 Provides Information HIV-infected infants respond poorly to childhood vaccination It is known that HIV-infected children who do not receive appropriate antiretroviral drugs experience immune depression, and may become susceptible to infectious diseases that would otherwise be prevented by childhood immunization. Open Open Tab December 6, 2007 Provides Information HIV-TB Spreads In Africa, Undermines Control Of World's Two Deadliest Infectious Diseases The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. Open Open Tab November 4, 2007 Provides Information HIV's double hit on brain cells HIV can trigger learning and memory deficits by launching a double attack on the brain, research shows. Open Open Tab August 16, 2007 Provides Information HIV, AIDS Vaccines Within a Decade? Vaccinations will be created for each of the "big three" killers—HIV/AIDS, tuberculosis and malaria - within the next decade, world health crusader Sir Gustav Nossal said today. Open Open Tab September 20, 2007 Provides Information HIV/AIDS cases among adults ages 50, older in Georgia increasing New HIV/AIDS diagnoses among adults ages 50 and older in Georgia has nearly doubled in the last 10 years, according to recent data from the state Department of Human Resources' Division of Public Health. Open Open Tab July 2, 2008 Provides Information HIV/AIDS cases increasing among sex workers in Uganda HIV/AIDS cases are increasing among women and girls involved in commercial sex work in Kampala, Uganda, HIV/AIDS advocates said recently Open Open Tab May 13, 2008 Provides Information HIV/AIDS implementers' meeting closes in Uganda; participants call for increased prevention efforts The 2008 HIV/AIDS Implementers' Meeting in Kampala, Uganda, closed on Saturday with participants calling for an increase in efforts to prevent the spread of the virus worldwide. Open Open Tab June 10, 2008 Provides Information HIV/AIDS major security threat to military forces, Ugandan general says at implementers' conference HIV/AIDS is a major security threat to the military, Ugandan Gen. Katumba Wamala, commander of the country's Land Forces, said recently at the 2008 HIV/AIDS Implementers' Meeting in Kampala, Uganda, the New Vision/AllAfrica.com reports. Open Open Tab June 8, 2008 Provides Information HIV/AIDS prevention strategies for Ukraine discussed at Canadian forum According to the Free Press, Ukraine has reported more annual HIV/AIDS-related deaths than any other European country. Injection drug use, mother-to-child transmission and unprotected sex are the main routes of transmission in the country, the Free Press reports. Open Open Tab April 18, 2008 Provides Information Home-based HIV voluntary counseling and testing in developing countries A review of existing research suggests that people in two African countries prefer taking HIV tests at home, with the assistance of counselors, instead of at a clinic. Open Open Tab October 17, 2007 Provides Information House Panel OKs Increase for Bush's HIV-AIDS Program A House committee on Wednesday voted to more than triple spending for a global AIDS program that has proven to be one of the Bush administration's most successful and popular foreign policy initiatives. Open Open Tab February 27, 2008 Provides Information How HIV Hides Itself Researchers have discovered how Human Immunodeficiency Virus (HIV), which causes AIDS, can hide itself in our cells and dodge the attention of our normal defences, scientists explained on 1 April 2008 at the Society for General Microbiology's 162nd meeting being held at the Edinburgh International Conference Centre. Open Open Tab April 2, 2008 Provides Information How HIV Turns Food-poisoning Into Lethal Infection Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea. Now, UC Davis School of Medicine scientists have discovered how salmonella becomes lethal for AIDS patients. Open Open Tab March 24, 2008 Provides Information How Stealthy HIV Protein Gets Into Cells Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didn't know how it worked. Open Open Tab March 20, 2008 Provides Information Human Protein May Offer Novel Target For Blocking HIV Infection: Successful In Lab A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. Open Open Tab April 29, 2008 Provides Information I Imitating Monkey's 'Jumping Genes' Could Lead To New Treatments For HIV UCL (University College London) scientists have taken a significant step in understanding how retroviruses such as HIV can move between species and the biological mechanisms behind the 'jumping genes' which make some monkeys immune. Open Open Tab February 19, 2008 Provides Information Implications Of The New HIV Estimate For India The 2007 UNAIDS/WHO AIDS epidemic update recently released has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people. Open Open Tab December 4, 2007 Provides Information Increased research, determination needed in HIV/AIDS vaccine efforts, HIV vaccine enterprise head says The disappointment that followed the cancellation of a Merck vaccine trial in September 2007 has been replaced by a renewed determination among the scientific community, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise Open Open Tab May 13, 2008 Provides Information India reduces rate of HIV transmission in some states According to the report, titled "Redefining AIDS in Asia: Crafting an Effective Response," about 440,000 people die annually of AIDS-related causes in Asia, and the rate is expected to rise to about 500,000 by 2020 if measures are not taken. Open Open Tab July 3, 2008 Provides Information Infected Babies Pass HIV to Mothers Not long ago, she was a wife, mother and teacher. Now Dilfuza Mustafakulova is HIV-positive and has lost her husband and her job. Mustafakulova's baby son was among 72 children infected with the virus at two Kyrgyz hospitals. Sixteen mothers also have contracted it — in some cases by breast-feeding their children. Open Open Tab April 10, 2008 Provides Information International Narcotics Control Board 'out of step' with HIV/AIDS control efforts, opinion piece says The control board is an independent body of 13 members who are elected by U.N. members and oversee the implementation of international drug control regulations, according to the authors. Open Open Tab May 30, 2008 Provides Information Intervening In The Deadly Cycle Of HIV Reproduction When a host cell is infected with HIV, the virus brings its own genetic material into the host cell. This cell then replicates, reads the viral RNA, and uses it as a blueprint to produce more viral proteins. Open Open Tab November 6, 2007 Provides Information J Japan awards new prize for HIV/AIDS, malaria work in Africa The prize is named after a well-known Japanese bacteriologist and provides 100 million yen, or about $1 million, to each recipient. Open Open Tab May 30, 2008 Provides Information K Kashmir faces unique challenges in HIV/AIDS fight Kashmir, which is controlled by India in the south and Pakistan in the north, faces many unique challenges in the fight against HIV/AIDS, IANS/DailyIndia.com reports. According to IANS/DailyIndia.com, there are 745 reported HIV cases in Kashmir; however, unofficial estimates put the number at 25,000. Open Open Tab   Provides Information Keeping Young South Africans In School: A 'Social Vaccine' Against AIDS A new study suggests that secondary school attendance is linked to lower risk of HIV infection among young people in rural South Africa. Open Open Tab January 17, 2008 Provides Information Kenyan Health Ministry launches HIV, TB communication campaign to reduce stigma, discrimination among health workers The East African on Monday examined how a campaign recently launched in Kenya to increase awareness about HIV/AIDS and tuberculosis will affect health care workers in the country. Open Open Tab June 8, 2008 Provides Information Key Roadblock To Gene Expression Identified: Implications For AIDS A team of scientists has provided, for the first time, a detailed map of how the building blocks of chromosomes, the cellular structures that contain genes, are organized in the fruit fly Drosophila melanogaster. Open Open Tab May 9, 2008 Provides Information Kyrgyzstan rocked by HIV scandal Fourteen medical workers in Kyrgyzstan have been charged with malpractice and negligence after 42 children were infected with HIV. Open Open Tab March 20, 2008 Provides Information L Latino Commission on AIDS Project focuses on HIV/AIDS among Hispanic immigrants in deep south The project aims to develop strategies to address HIV/AIDS among Hispanics in Mississippi and six other Southern states with rapidly growing populations of new immigrants, Frasca, program coordinator for the project, said. Open Open Tab May 11, 2008 Provides Information Living condom gives protection from AIDS Scientists in Australia have developed a natural condom which could prevent the spread of AIDS. Open Open Tab June 5, 2008 Provides Information M Major Shift In HIV Prevention Priorities Needed, Analysts Urge According to a new policy analysis led by researchers at the Harvard School of Public Health (HSPH) and the University of California, Berkeley, the most common HIV prevention strategies--condom promotion, HIV testing, treatment of other sexually transmitted infections (STIs), vaccine and microbicide research, and abstinence--are having a limited impact on the predominantly heterosexual epidemics found in Africa. Open Open Tab May 11, 2008 Provides Information Many still denied HIV drug access Millions of people with HIV/Aids in poor countries still do not have access to potentially life-saving drugs. Open Open Tab June 2, 2008 Provides Information Massachusetts Jury Awards $2.5. Million to Woman Who Underwent Nine Years of Unnecessary HIV Treatments In her lawsuit against a doctor who treated her, Audrey Serrano said the powerful combination of drugs she took triggered a string of ailments, including depression, chronic fatigue, loss of weight and appetite and inflammation of the intestine. Open Open Tab December 13, 2007 Provides Information Matching Pathogens To Their Antibodies: Could Lead To HIV Vaccine The search for a vaccination against HIV has been in progress since 1984, with very little success. Open Open Tab October 15, 2007 Provides Information Membrane Nanotubes may Hold the Key to How HIV Virus Infects Human Immune Cells String-like connections found between T-cells could be important to how HIV spreads between cells in the human immune system, according to new research published online in Nature Cell Biology. Open Open Tab January 15, 2008 Provides Information Merck/Gilead once-a-day AIDS pill not available in most places AIDS Healthcare Foundation (AHF) today called on Gilead Sciences and Merck to immediately register and distribute the three-in-one, once daily lifesaving HIV treatment, Atripla, in developing countries. Open Open Tab September 10, 2007 Provides Information microRNAs may be key to HIV's ability to hide, evade drugs Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Open Open Tab October 1, 2007 Provides Information Molecular espionage shows a single HIV enzyme's many tasks Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus' fierce attack on host cells. Open Open Tab May 7, 2008 Provides Information Molecular Espionage Shows A Single HIV Enzyme's Many Tasks Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus' fierce attack on host cells. Open Open Tab May 9, 2008 Provides Information Moms Pre-Chewing Food Gave HIV to Kids, Scientists Say For the first time, health officials report that the AIDS virus can be spread by a mother pre-chewing her infant's food, a practice mainly seen in poor, developing countries. Open Open Tab February 6, 2008 Provides Information Monkeys Able To Fend Off AIDS-like Symptoms With Enhanced HIV Vaccine Researchers at the University of Pennsylvania School of Medicine have discovered that using an immune system gene to enhance a vaccine used to study HIV in macaque monkeys provides the animals with greater protection against simian HIV (SHIV) than an unmodified vaccine. Open Open Tab November 26, 2007 Provides Information Monkeys fend off AIDS-like symptoms with enhanced HIV vaccine Researchers at the University of Pennsylvania School of Medicine have discovered that using an immune system gene to enhance a vaccine used to study HIV in macaque monkeys provides the animals with greater protection against simian HIV (SHIV) than an unmodified vaccine. Open Open Tab November 21, 2007 Provides Information Monkey Gene That Blocks AIDS Viruses Evolved More Than Once Researchers at Harvard Medical School have identified a gene in Asian monkeys that may have evolved as a defense against lentiviruses, the group of viruses that includes HIV. The study suggests that AIDS is not a new epidemic. Open Open Tab March 3, 2008 Provides Information Most Effective Initial Therapy For HIV-1 Infection Identified In the largest study of its kind to evaluate commonly used HIV drugs, researchers at the University of Pittsburgh School of Medicine confirmed that one of the most frequently prescribed triple-drug combinations for initial HIV infection is, indeed, the most effective at suppressing HIV. Open Open Tab May 16, 2008 Provides Information Most HIV cases traced to transmission of single virus the findings are surprising and could have an impact on HIV/AIDS vaccine development. Open Open Tab May 22, 2008 Provides Information Mouse model shows potential efficacy of HIV prevention strategy A new kind of laboratory mouse can be used to test the efficacy of much-needed methods to prevent transmission of HIV, the virus that causes AIDS, according to research by J. Victor Garcia and colleagues at the University of Texas Southwestern Medical Center in Dallas. Open Open Tab January 15, 2008 Provides Information Mutated HIV Suggests New Approach to AIDS People whose immune systems are uniquely predisposed to hunting down HIV are causing the virus to mutate into a weaker form, suggesting a new tactic for fighting AIDS. Open Open Tab March 21, 2008 Provides Information N Nanotechnology Based HIV Drug Goes into Animal Trials NanoViricides, Inc., said that preliminary animal trials of the Company's HIV therapeutic candidates have begun at a BioSafety Level 3 (BSL-3) Laboratory facility in Boston, MA. The initial results are expected before the end of next month. These animal studies will be conducted by Dr. Krishna Menon, PhD, VMD, MRCS, a world-renowned authority in preclinical and toxicological studies of innovative therapeutics. Open Open Tab April 8, 2008 Provides Information NanoViricides Anti-HIV Drug Candidate Demonstrated Superior Survival Time NanoViricides, Inc., said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV "combo cocktail" in a double-blind animal study. The three-drug combo "cocktail" used for comparison is one of the most frequently used triple combination therapies in humans. Open Open Tab June 17, 2008 Provides Information NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model NanoViricides, Inc. said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV "combo cocktail” in a double-blind animal study. The three-drug combo "cocktail” used for comparison is one of the most frequently used triple combination therapies in humans. Open Open Tab June 16, 2008 Provides Information New AIDS Medication Approved by FDA The Food and Drug Administration has approved a new anti-AIDS pill, an option for hard-to-treat patients. Open Open Tab October 12, 2007 Provides Information New AIDS Vaccine Fails to Work, Major Study Halted In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study. Open Open Tab September 22, 2007 Provides Information New Approach Stops HIV At Earliest Stage Of Infection To date, more than a dozen candidate vaccines, which have attempted to raise immunity against the spiky proteins on the viral envelope, have all failed in clinical testing. Open Open Tab February 28, 2008 Provides Information New approach to HIV vaccine research taps Rochester expertise A new national effort to create a vaccine against HIV will include work by a University of Rochester Medical Center rheumatologist who is an expert on a portion of the immune system that has sometimes gotten short shrift in the fight against HIV. Open Open Tab June 30, 2008 Provides Information New five-year course for U.S. AIDS response As a fitting tribute to the late Committee Chairman Tom Lantos, Republicans and Democrats have crafted a bipartisan compromise to support AIDS, TB and malaria policy. Open Open Tab February 28, 2008 Provides Information New HIV Vaccine Target Could Solve Mutation Problem Researchers at UCSF and the University of Toronto have identified a potential new way of fighting against HIV infection that relies on the remnants of ancient viruses, human endogenous retroviruses (HERV), which have become part of the genome of every human cell. Open Open Tab November 12, 2007 Provides Information New Hope For HIV Patients: Potent Peptides Inhibit HIV Entry Into Cells Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class. Open Open Tab October 11, 2007 Provides Information New Hope For HIV Vaccine: Unique HIV Vaccine Formula Elicits Strong Immune Responses Advanced BioScience Laboratories, Inc. (ABL) and the University of Massachusetts Medical School (UMMS) report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers. In light of these initial findings, additional assays on volunteers' samples were done by researchers at the University of Alabama at Birmingham, independently confirming the presence of long lasting and high quality T cell responses against HIV antigens. Open Open Tab May 23, 2008 Provides Information New information on HIV genetic switch If the battle against HIV, the virus that causes AIDS, is a chess match, then new research published today gives new insight into one of the virus' most important moves. Open Open Tab March 18, 2008 Provides Information New Insights Into Role Of Breastfeeding In Preventing Infant Death, HIV Infection In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk--or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy. Now, two studies supported by the National Institutes of Health offer insights into preventing early death and HIV infection among breastfeeding infants of mothers with HIV in these countries. Open Open Tab June 6, 2008 Provides Information New Insights Into Vaccination For HIV The study shows that both prior vaccination and timing influence the rates of immune escape, providing further insight into the effectiveness of T cell immunity to HIV. Open Open Tab January 31, 2008 Provides Information New Peptides to Fight HIV Investigators working at the National Synchrotron Light Source (NSLS) at the Brookhaven National Laboratory discovered new peptides that seem to block the entry of HIV particles into cells quite effectively. Open Open Tab October 9, 2007 Provides Information New Picture Of HIV-1's Protein Jacket Identifies Target For Antibody-based Vaccine By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, or so-called broadly neutralizing, antibodies block HIV-1 infection. Open Open Tab January 11, 2008 Provides Information New Pfizer HIV drug approved for sale in Europe Drug giant Pfizer has been given approval for it's new HIV drug Celsentri to go on sale in Europe. Open Open Tab September 24, 2007 Provides Information New plan for HIV marriage tests A committee set up by the Indian state of Maharashtra has provisionally approved the mandatory HIV testing of couples before marriage. Open Open Tab January 31, 2008 Provides Information New Resistance Mechanism To Anti-HIV Drugs Discovered A recent study at the Centro de Biología Molecular “Severo Ochoa”, (CSIC-UAM) discovers the existence of a mechanism that compensates for the lack of reverse transcriptase. This mechanism builds resistance to some drugs at preclinical development phase. Open Open Tab January 28, 2008 Provides Information New Saliva-based HIV Test May Speed Up Detection The usual waiting period for the results of a HIV test can seem like an eternity, especially in emergency situations where results are needed immediately. Also it requires a blood sample, which is invasive and often painful. Recognizing the urgent need for a faster and less invasive diagnostic method, Dr. Nitika Pant Pai, from Marina Klein's research team at the MUHC has just finished testing a new saliva-based test that gives results in approximately 20 minutes. Open Open Tab May 6, 2008 Provides Information New Strategy Could Dramatically Slow The Spread Of HIV Giving a daily antiretroviral pill to people to prevent HIV could profoundly slow the spread of the infection in sub-Saharan Africa, where it is a full-blown epidemic, University of Pittsburgh School of Medicine researchers report. Open Open Tab September 22, 2007 Provides Information New technology tracks medication adherence in patients with HIV/AIDS Most of us have missed a dose of antibiotic or forgotten to take a daily vitamin. But when the stakes are higher - as they are for people with HIV/AIDS - a skipped pill could mean the difference between health and hazard for the entire population. Open Open Tab April 21, 2008 Provides Information NIAID creates HIV vaccine discovery branch To accelerate the translation of basic discoveries about HIV into advances in vaccine design and evaluation, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has formed a new Vaccine Discovery Branch within the Vaccine Research Program in the Division of AIDS (DAIDS). Open Open Tab June 25, 2008 Provides Information Number of HIV cases among seniors in Puerto Rico increasing According to the Herald, 238 new HIV cases were recorded among people over age 60 during the year ending in September 2007 -- a 25% increase compared with the same time period in 2006. Open Open Tab January 30, 2008 Provides Information Nurse Died From AIDS Seven Years After Accidental Needle Prick A 42-year-old nurse died from AIDS seven years after she accidentally pricked her thumb with a needle she had used on a patient, an inquest in the U.K. was told this week. Open Open Tab February 13, 2008 Provides Information O One HIV Subtype More Deadly Than Others According to the researchers, the shorter survival time measured in the studies suggests that HIV subtype E, which is the most common HIV subtype in Thailand, may be more virulent than other subtypes of the virus. Open Open Tab November 30, 2007 Provides Information One-third of patients receiving HIV medication in Africa don't continue treatment More than one-third of patients receiving HIV medication in Africa die or discontinue their treatment within two years, according to a study published in PLoS Medicine. Open Open Tab October 17, 2007 Provides Information Online Intervention Paramount For Reducing HIV In High-risk Population Young Internet-using men who have sex with men AND who meet their sexual partners both online and offline have greater numbers of partners, appear more likely to contract HIV, and report higher substance use rates than those who meet their partners exclusively online or offline, according to new research at the University of Minnesota. Open Open Tab April 30, 2008 Provides Information Organ transplantation for HIV-positive patients Not long ago, organ transplantation was not considered an option for HIV infected patients. Open Open Tab September 17, 2007 Provides Information Outcry at Tanzanian HIV beating There has been an outcry in Tanzania over a woman who was badly injured by her husband after she took an HIV test which is being encouraged nationwide. Open Open Tab November 28, 2007 Provides Information P PNG Coalition Against HIV/AIDS to implement programs in businesses nationwide According to Mitchell, the coalition trains business leaders to educate workers on policies and principles regarding HIV/AIDS. The coalition also helps businesses develop and coordinate the involvement of other stakeholders in implementing HIV education into the workplace. Open Open Tab February 4, 2008 Provides Information Pregnancy appears to cut risks for HIV-infected women Women with HIV infection who become pregnant have a lower risk of progression to AIDS and death, researchers at Vanderbilt University Medical Center report. Open Open Tab September 14, 2007 Provides Information Pregnancy May Slow -- Not Accelerate -- Progression To AIDS A new study may help put to rest fears that pregnancy accelerates progression to full-blown AIDS in women with HIV receiving antiretroviral therapy. The study, published in the October 1st issue of the Journal of Infectious Diseases and now available online, revealed that pregnancy may, in fact, slow disease progression in these women. Open Open Tab September 21, 2007 Provides Information Premier forum on AIDS focuses on vaccine against HIV An international conference on AIDS has gathered together over 900 global researchers, clinicians and specialists for the 2007 AIDS Vaccine Conference in Seattle. Open Open Tab August 21, 2007 Provides Information Protein Discovered That Prevents HIV From Spreading n a study that could open up the field of virology to an entirely new suite of possibilities and that paves the way for future drug research, scientists at Rockefeller University and the Aaron Diamond AIDS Research Center have pinned down a molecule on the surface of human cells that helps keep particles of mutant strains of HIV from spreading. Open Open Tab January 25, 2008 Provides Information Protein In Deer Tick Saliva Prevents HIV-1 From Attaching To T Cells The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections. A recent study by researchers from the University of Massachusetts Amherst shows that a protein found in the saliva of deer ticks prevents the HIV-1 virus from attaching to the surface of T cells, which is the critical first step in the virus' attack strategy. Open Open Tab February 21, 2008 Provides Information R Rapid HIV tests highly effective in preventing mother-to-child HIV transmission in India Rapid HIV tests have been found to be highly effective in preventing mother-to-child HIV transmission in clinical trials in India, according to a study published online Tuesday in PLoS Medicine. Open Open Tab May 8, 2008 Provides Information Renewal of AIDS Program Won't Be a Problem To hear President Bush tell it, his program to combat AIDS across Africa faces an uncertain future in Congress. His wife is not so worried. Open Open Tab February 17, 2008 Provides Information Report on HIV/AIDS drug access shows 'encouraging, painfully slow progress,' editorial says The report found that although the rate of HIV/AIDS-related deaths "continues to decline," almost "2.5 million new infections were recorded last year," the editorial says, adding that the 3 by 5 Initiative target" has been met, but two years after the target date." Open Open Tab June 8, 2008 Provides Information Researchers discover how stealthy HIV protein gets into cells Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didn't know how it worked. Open Open Tab March 18, 2008 Provides Information Researchers examine immune cells where HIV can lie dormant, possible treatments Researchers have determined how HIV is able to lie dormant in certain immune system cells and prevent the cells from self-destructing, according to a study published Thursday online in the journal Retrovirology. Open Open Tab February 4, 2008 Provides Information Researchers Synthesize Compound To Flush HIV Out Of Hiding And Into Crosshairs Any hunter will tell you that when your quarry goes into hiding, you have to flush it out to get a good shot at it. Such is the case with HIV, the virus that causes AIDS. Open Open Tab May 4, 2008 Provides Information Researchers Tackle HIV From a New Angle Most drugs aimed at suppressing HIV target proteins lying on the virus itself, but new research suggests that focusing on the human host's immune cells might work even better. Open Open Tab April 29, 2008 Provides Information Ryan White funding proposal demonstrates neglect of US' growing AIDS epidemic AIDS Healthcare Foundation (AHF) has strongly criticized Ryan White CARE Act funding levels contained in the latest budget package drafted by Congress in order to meet the restrictions of President George W. Bush's spending target for next year. Open Open Tab December 19, 2007 Provides Information S S Africa recalls faulty condoms South Africa's health department has recalled millions of condoms given out under a programme it funded. Open Open Tab August 28, 2007 Provides Information SA survey hints at HIV decrease The South African government says that for the first time, there may be signs of a reduction in the prevalence of HIV, the virus that causes Aids. Open Open Tab August 2, 2007 Provides Information Saving lives with leftover AIDS drugs Jesus Aguais was working as an AIDS counselor for Latino patients when a woman from his native Venezuela entered his New York medical center office with a desperate plea. Open Open Tab August 28, 2007 Provides Information Scientists discover how HIV evolves University of Florida scientists have discovered how HIV evolves over the course of a person's lifetime into a more deadly form that heralds the onset of full-blown AIDS. Open Open Tab October 17, 2007 Provides Information Scientists find new cellular receptor for HIV A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Open Open Tab February 11, 2008 Provides Information Scientists Get Inside A Long-suspected HIV Hideout In Humans Scientists have broken inside a cell long suspected of harboring HIV during drug treatment and determined it is indeed a reservoir of the virus in humans, where it remains highly infectious. Open Open Tab May 15, 2008 Provides Information Scientists Identify Proteins Hijacked by AIDS The AIDS virus has to hijack human proteins to do its damage, but scientists until now have known only a few dozen of its targets. On Thursday, Harvard researchers unveiled a surprisingly longer list, an important first step in the hunt for new drugs. Open Open Tab January 11, 2008 Provides Information Scientists Test Device To Track Medication Adherence In Patients With HIV/AIDS Most of us have missed a dose of antibiotic or forgotten to take a daily vitamin. But when the stakes are higher -- as they are for people with HIV/AIDS -- a skipped pill could mean the difference between health and hazard for the entire population. Open Open Tab April 22, 2008 Provides Information Second HIV/AIDS implementers' meeting opens in Uganda The 2008 HIV/AIDS Implementers' Meeting opened on Tuesday in Kampala, Uganda, and is expected to bring together 1,700 participants to discuss ways to bolster the global response to the disease, the New Vision/AllAfrica.com reports.